Therapixel

Therapixel is a leading French software company specializing in artificial intelligence for medical imaging, with a focus on efficient breast cancer screening. Their AI algorithm achieved a milestone by winning the Digital Mammography DREAM Challenge, the largest Artificial Intelligence challenge ever organized. In its early years, Therapixel developed image visualization software for surgeons, streamlining image access from patient consultation to the operating room using gesture control and intuitive user interfaces. The company, founded in 2013, operates at the intersection of AI, Health Care, Medical Devices, and Machine Learning, with its headquarters based in France. Notably, Therapixel has secured a significant €15.00M Series B investment on May 12, 2022. The investment was led by a consortium of investors including Omnes Capital, Verve Ventures, Crédit Mutuel Innovation, Elaia, Région Sud Investissement, Fraser, M Capital Partners, IT-Translation, CapHorn Invest, and Sham.